Cannabinoid Hyperemesis Syndrome.

Cannabinoid hyperemesis syndrome is reviewed in JAMA Insights, summarizing its pathophysiology, clinical presentation, and epidemiology with associated risk factors.

• Why it matters: The condition’s mechanisms, how it presents clinically, and who is at risk are important gaps for recognizing and managing recurrent cannabinoid-associated vomiting.
• What they did: The article synthesizes current knowledge on cannabinoid hyperemesis syndrome, covering pathophysiology, clinical presentation, and epidemiology and risk factors.
• The result: Readers gain a consolidated understanding that supports improved identification of cannabinoid hyperemesis syndrome and informs risk-factor awareness.

AI summary of the abstract · may contain errors · not medical advice · read the paper.